Page 2 - Making Insights News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Making insights. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Making Insights Today - Breaking & Trending Today

Bionaut Labs launches with plans to attack brain tumors with tiny, guided robots


Mar 3, 2021 3:05am
Bionaut Labs small, remote-controlled devices can overcome the obvious constraint that holds back surgical drills, probes and needles: once they’re in the body, they can’t turn. (Getty Images)
The robots are coming: After working under the radar for four years, Bionaut Labs is raising the curtain on its tiny, remote-controlled devices, built to travel through the human body and deliver a dose of medicine where it’s needed the most.
Smaller than a millimeter and with a few moving parts, the tiny voyagers are designed to navigate through tissues and go where today’s surgeons cannot, such as when dealing with hard-to-reach cancers. ....

Neurocrine Biosciences , Errol Desouza , Vinod Khosla , Michael Shpigelmacher , Insights For The Life Sciences Industry , Bionaut Labs , Making Insights , Life Sciences , Jon Mckee Photography , Los Angeles Based , Khosla Ventures , Upfront Ventures , Venture Capital Vc , Medical Device , Glioblastoma Multiforme Gbm , Robotic Surgery , எரொல் டெசௌசா , வினோத் கோசில , நுண்ணறிவு க்கு தி வாழ்க்கை அறிவியல் தொழில் , தயாரித்தல் நுண்ணறிவு , வாழ்க்கை அறிவியல் , ஜான் மகீ புகைப்படம் எடுத்தல் , லாஸ் ஏஞ்சல்ஸ் அடிப்படையிலானது , கோசில முயற்சிகள் , வெளிப்படையான முயற்சிகள் , துணிகர மூலதனம் வ்ஸீ ,

European VC Sofinnova Partners raises $540M late-stage crossover healthcare fund


(Pixabay)
Sofinnova Partners has pulled in a healthy €445 million ($540 million) in its latest capital raise as the European venture capital firm seeks out late-stage plays in biotech and medtech.
The fund was “oversubscribed and significantly exceeded its target,” the Paris-based firm said, and with this latest cash boost it s set to continue its focus on European clinical-stage companies “needing scale-up capital” while also supporting “best-in-class companies” in the U.S. and elsewhere.
It did, not however, detail any particular targets it was going after. Other VC firms have said in a COVID-19 world they would focus more on conditions such as infectious diseases and other neglected R&D areas. ....

France General , Antoine Papiernik , Insights For The Life Sciences Industry , Sofinnova Partners , Making Insights , Life Sciences , Venture Capital Vc , பிரான்ஸ் ஜநரல் , அன்டோயின் பப்பிேர்னிக் , நுண்ணறிவு க்கு தி வாழ்க்கை அறிவியல் தொழில் , தயாரித்தல் நுண்ணறிவு , வாழ்க்கை அறிவியல் , நிதி திரட்டல் , துணிகர மூலதனம் வ்ஸீ ,